If you need more lookups,
subscriptions start at $34 USD/month.
Amber Salzman Location
United States
Amber Salzman Work
CEO @ (October 2021 - Present)
Board Member @ Aviado Bio (February 2021 - Present)
Board Member @ (June 2020 - Present)
Board Member @ (October 2020 - Present)
President and CEO @ (July 2018 - September 2021)
Board Member @ Akcea Therapeutics (February 2020 - October 2020)
CEO and President @ (October 2016 - May 2018)
President and Chief Operating Officer @ (May 2016 - October 2016)
President and CEO @ Annapurna Therapeutics (January 2012 - May 2016)
President and CEO @ (May 2009 - December 2011)
President @ Venuvics Pharmaceuticals Inc. (May 2008 - May 2009)
SVP Medicine Development Operations @ (January 2000 - January 2008)
SVP @ (July 1983 - January 2000)
Amber Salzman Education
Bryn Mawr College
PhD (Mathematics)
Temple University
BA (Computer Science)
Amber Salzman Skills
Medicine
Pharmaceutical Industry
CTMS
Oncology
Lifesciences
Regulatory Submissions
Venture Capital
Biotechnology
Entrepreneurship
Commercialization
Cross-functional Team Leadership
Clinical Trials
CRO
Drug Development
FDA
GCP
Clinical Development
Regulatory Affairs
Gene Therapy
Leadership
Project Management
Sales
Strategy
Development
Microsoft Office
Business Development
Business Analysis
Clinical Research
Cross Functional Team Leadership
Portfolio Management
Hospitals
21 CFR Part 11
Strategic Planning
Biopharmaceuticals
Amber Salzman Summary
Amber Salzman, based in United States, is currently a CEO at Epicrispr Biotechnologies. Amber Salzman brings experience from previous roles at Aviado Bio, Osler Diagnostics, Biotechnology Innovation Organization and Ohana Biosciences, Inc.. Amber Salzman holds a PhD in Mathematics @ Bryn Mawr College. With a robust skill set that includes Medicine, Pharmaceutical Industry, CTMS, Oncology, Lifesciences and more. Amber Salzman has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Amber Salzman?
Find contact details for 700 million professionals.